SCHEMBL31051471

SCHEMBL31051471

Cl[13c]1[13cH][13c](Cl)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28153591 0.96 MEN1 (0.40)
Methylene Chloride SCHEMBL27947432 0.90 MEN1 (0.38)
SCHEMBL29136970 0.83 KMO (0.44)
Isopropyl Alcohol SCHEMBL28207243 0.83 NPC1 (0.35)
Acetaldehyde SCHEMBL28232456 0.83 NPC1 (0.35)
Chlorobenzene SCHEMBL27930649 0.81 TSHR (0.55)
Bicarbonate SCHEMBL28202844 0.81 KMO (0.33)
SCHEMBL4146204 0.78
SCHEMBL6128470 0.78
SCHEMBL9970864 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275728-B2 O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors BIOGEN MA INC. (US) 2025-04-15 US disclosed
US-12180205-B2 O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors BIOGEN MA INC. (US) 2024-12-31 US disclosed
US-20240308995-A1 O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. 2024-09-19 US disclosed
CN-113166137-B O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranoside enzyme inhibitors 比奥根MA公司 2024-08-16 CN disclosed